Literature DB >> 25806188

Gene therapy for lung cancer malignant pleural effusion: current and future nano-biotechnology.

Paul Zarogoulidis1, Kalliopi Domvri1, Haidong Huang2, Konstantinos Zarogoulidis1.   

Abstract

Entities:  

Year:  2012        PMID： 25806188      PMCID： PMC4367546          DOI： 10.3978/j.issn.2218-6751.2012.08.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  25 in total

1.  Adenoviral gene transfer is inhibited by soluble factors in malignant pleural effusions.

Authors:  R K Batra; S M Dubinett; B W Henkle; S Sharma; B K Gardner
Journal:  Am J Respir Cell Mol Biol       Date:  2000-05       Impact factor: 6.914

2.  A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.

Authors:  Daniel H Sterman; Adri Recio; Richard G Carroll; Colin T Gillespie; Andrew Haas; Anil Vachani; Veena Kapoor; Jing Sun; Richard Hodinka; Jennifer L Brown; Michael J Corbley; Michael Parr; Mitchell Ho; Ira Pastan; Michael Machuzak; William Benedict; Xin-qiao Zhang; Elaina M Lord; Leslie A Litzky; Daniel F Heitjan; Carl H June; Larry R Kaiser; Robert H Vonderheide; Steven M Albelda; Michelle Kanther
Journal:  Clin Cancer Res       Date:  2007-08-01       Impact factor: 12.531

Review 3.  [Structure and physiology of the pleura and the pleural space].

Authors:  J-F Bernaudin; J Fleury-Feith
Journal:  Rev Pneumol Clin       Date:  2006-04

4.  A strategy for adenovirus vector targeting with a secreted single chain antibody.

Authors:  Joel N Glasgow; Galina Mikheeva; Victor Krasnykh; David T Curiel
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

Review 5.  Cationic polymer optimization for efficient gene delivery.

Authors:  Xiaoli Sun; Na Zhang
Journal:  Mini Rev Med Chem       Date:  2010-02       Impact factor: 3.862

6.  Optimized PEGylated adenovirus vector reduces the anti-vector humoral immune response against adenovirus and induces a therapeutic effect against metastatic lung cancer.

Authors:  Yusuke Eto; Yasuo Yoshioka; Tatsuhiro Ishida; Xinglei Yao; Tomohiro Morishige; Shogo Narimatsu; Hiroyuki Mizuguchi; Yohei Mukai; Naoki Okada; Hiroshi Kiwada; Shinsaku Nakagawa
Journal:  Biol Pharm Bull       Date:  2010       Impact factor: 2.233

Review 7.  Drug penetration in solid tumours.

Authors:  Andrew I Minchinton; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

8.  Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy.

Authors:  Sergey S Seregin; Daniel M Appledorn; Aaron J McBride; Nathaniel J Schuldt; Yasser A Aldhamen; Tyler Voss; Junping Wei; Matthew Bujold; William Nance; Sarah Godbehere; Andrea Amalfitano
Journal:  Mol Ther       Date:  2009-01-27       Impact factor: 11.454

9.  Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.

Authors:  K Otake; D L Ennist; K Harrod; B C Trapnell
Journal:  Hum Gene Ther       Date:  1998-10-10       Impact factor: 5.695

10.  Advanced malignant pleural or peritoneal effusion in patients treated with recombinant adenovirus p53 injection plus cisplatin.

Authors:  M Dong; X Li; L-J Hong; R Xie; H-L Zhao; K Li; H-H Wang; W-D Shin; H-J Shen
Journal:  J Int Med Res       Date:  2008 Nov-Dec       Impact factor: 1.671
View more
  2 in total

Review 1.  Prodrugs and prodrug-activated systems in gene therapy.

Authors:  Semira Sheikh; Daniel Ernst; Armand Keating
Journal:  Mol Ther       Date:  2021-04-06       Impact factor: 11.454

2.  Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy.

Authors:  Robert Fred Henry Walter; Claudia Vollbrecht; Robert Werner; Thomas Mairinger; Jan Schmeller; Elena Flom; Jeremias Wohlschlaeger; Nikolaos Barbetakis; Dimitrios Paliouras; Fotios Chatzinikolaou; Vasilis Adamidis; Kosmas Tsakiridis; Paul Zarogoulidis; Georgia Trakada; Daniel Christian Christoph; Kurt Werner Schmid; Fabian Dominik Mairinger
Journal:  J Cancer       Date:  2016-09-13       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.